Quantinno Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.9M | Buy |
245,440
+8,393
| +4% | +$579K | 0.07% | 317 |
|
|
2025
Q1 | $16.5M | Buy |
237,047
+25,181
| +12% | +$1.75M | 0.11% | 198 |
|
|
2024
Q4 | $18.2M | Buy |
211,866
+9,885
| +5% | +$850K | 0.18% | 73 |
|
|
2024
Q3 | $24M | Buy |
201,981
+16,995
| +9% | +$2.02M | 0.31% | 42 |
|
|
2024
Q2 | $26.4M | Buy |
184,986
+64,769
| +54% | +$9.25M | 0.47% | 27 |
|
|
2024
Q1 | $15.4M | Buy |
120,217
+3,793
| +3% | +$487K | 0.34% | 43 |
|
|
2023
Q4 | $12M | Sell |
116,424
-4,985
| -4% | -$516K | 0.42% | 28 |
|
|
2023
Q3 | $11M | Buy |
121,409
+80,195
| +195% | +$7.29M | 0.5% | 25 |
|
|
2023
Q2 | $3.34M | Buy |
41,214
+4,386
| +12% | +$355K | 0.19% | 90 |
|
|
2023
Q1 | $2.93M | Buy |
36,828
+6,624
| +22% | +$527K | 0.19% | 99 |
|
|
2022
Q4 | $2.04M | Buy |
30,204
+13,944
| +86% | +$944K | 0.15% | 183 |
|
|
2022
Q3 | $810K | Buy |
16,260
+11,706
| +257% | +$583K | 0.1% | 251 |
|
|
2022
Q2 | $254K | Buy |
+4,554
| New | +$254K | 0.04% | 506 |
|